Plans for first Danish stem cell centre announced

23 November 2010

Private co-financing was apparently agreed to be essential for this new venture and certainly, the input from Novo Nordisk dwarfs that from the Danish government. The success of this heavily commercially-subsidised model will be watched with interest by other countries considering how best to fund future research in stem cells and regenerative medicine. One key issue will no doubt be ownership of IP on potential new tools and therapeutics.

More from us

Genomics and policy news